Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.01 - Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
10:30 - 10:40 | Presenter: Robert C. Doebele | Author(s): Myung-Ju Ahn, Salvatore Siena, Alexander Drilon, Matthew G Krebs, Chia-Chi Lin, Filippo G. De Braud, Thomas John, Daniel S.W. Tan, Takashi Seto, Rafal Dziadziuszko, Hendrick-Tobias Arkenau, Fabrice Barlesi, Christian Rolfo, Jürgen Wolf, Edna Chow-Maneval, Pratik S. Multani, Na Cui, Todd Riehl, Byoung Chul Cho
- Abstract
Loading... -
+
OA02.02 - Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
10:40 - 10:50 | Presenter: Jessica Jiyeong Lin | Author(s): Dong-Wan Kim, Alexander Drilon, Robert C. Doebele, Jeeyun Lee, Viola Zhu, Myung-Ju Ahn, John Lim, Shanna Stopatschinskaja, J. Jean Cui, David M Hyman, Ross Camidge, Sai-Hong Ignatius Ou, Alice T. Shaw, Byoung Chul Cho
- Abstract
Loading...
-
+
MA04 - Novel Approaches with IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA04.03 - Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations: New Results from the Global IMMUNOTARGET Registry
13:40 - 13:45 | Presenter: Oliver Gautschi | Author(s): Alexander Drilon, Julie Milia, Amelie Lusque, Laurent Mhanna, Bob T. Li, Joshua K Sabari, Alexis B Cortot, Benjamin Besse, Laura Mezquita, Ben J Solomon, Alesha A Thai, Sebastien Couraud, Remi Veillon, Céline Mascaux, Fabrice Barlesi, Michael Van Den Heuvel, Robert D Schouten, Heather A Wakelee, Angela Mah, Ross Camidge, Terry L. Ng, Nir Peled, Yosef Lilach, Sanjay Popat, Sai-Hong Ignatius Ou, Viola Zhu, Vamsidhar Velcheti, Alessandra Curioni Fontecedro, Dilara Akhoundova, Martin Früh, Gerard Zalcman, Valerie Gounant, Silvia Novello, Paolo Bironzo, Enriqueta Felip, Alex Martinez-Marti, Denis Moro-Sibilot, Rafael Rosell, Niki Karachaliou, Martin Schuler, Martin Wiesweg, Joachim Diebold, Julien Mazieres
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-74 - MET Exon 14-Altered Lung Cancers: Central Nervous System (CNS) Metastases and Patterns of CNS Progression on MET Inhibition.
16:45 - 18:00 | Presenter: Michael Offin | Author(s): Jordan Dienstag, Olivia Wilkins, Joshua K Sabari, Ai Ni, Daniel L. Feldman, Martine Van Voorthuysen, Ken Suzawa, Helena Yu, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark G Kris, Charles M. Rudin, Romel Somwar, Bob T. Li, Alexander Drilon
- Abstract
Loading... -
+
P1.01-99 - Detecting HER2 Alterations by Next Generation Sequencing (NGS) in Patients with Advanced NSCLC from the United States and China
16:45 - 18:00 | Presenter: Chong-Rui Xu | Author(s): Yi-Chen Zhang, Dazhi Liu, Ronglai Shen, Pedram Razavi, Si-Yang Liu, Hao Sun, Michael Offin, Alexander Drilon, Charles M. Rudin, Maria E Arcila, Yi-Long Wu, Bob T. Li
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-40 - Rapid, Robust and Durable Responses to Larotrectinib in Patients with TRK Fusion Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Anna F. Farago | Author(s): Shivaani Kummar, Shannon Ibabekci, Stefani Corsi-Travali, Scott Cruickshank, Michael C. Cox, Nora C. Ku, Alexander Drilon
- Abstract
Loading...
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.02 - Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
15:25 - 15:35 | Presenter: Alexander Drilon | Author(s): Jeffrey W. Clark, Jared Weiss, Sai-Hong Ignatius Ou, Ross Camidge, Ben J Solomon, Gregory A. Otterson, Liza Villaruz, Gregory J Riely, Rebecca Heist, Geoffrey I. Shapiro, Danielle A. Murphy, Sherry C. Wang, Tiziana Usari, Sherry Li, Keith D. Wilner, Paul K. Paik
- Abstract
Loading... -
+
OA12.07 - Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
16:20 - 16:30 | Presenter: Geoffrey R. Oxnard | Author(s): Vivek Subbiah, Keunchil Park, Todd M. Bauer, Lori J Wirth, Vamsidhar Velcheti, Manisha Shah, Benjamin Besse, Valentina Boni, Karen L. Reckamp, Herbert H Loong, Lyudmila Bazhenova, Ben J Solomon, Daniel S.W. Tan, Jyoti Patel, Melissa L. Johnson, Anas Gazzah, Tony S. Mok, Steve Smith, Brian Tuch, Kevin Ebata, Edward Y Zhu, Michele M Nguyen, Xin Huang, Scott Cruickshank, S Michael Rothenberg, Alexander Drilon
- Abstract
Loading...